We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $610M
1-Year Est. Return 40.86%
This Fund
S&P 500
This Quarter Est. Return
+38.56%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$39.4M
Cap. Flow
-$5.93M
Cap. Flow %
-2.71%
Top 10 Hldgs %
60.99%
Holding
47
New
12
Increased
12
Reduced
11
Closed
10

Top Buys

1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$7.8M
2
ANAB icon
AnaptysBio
ANAB
+$5.55M
3
NVST icon
Envista
NVST
+$4.69M
4
ORGO icon
Organogenesis Holdings
ORGO
+$3.92M
5
ALDX icon
Aldeyra Therapeutics
ALDX
+$3.69M

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
+$17M
2
HNGR
Hanger Inc.
HNGR
+$8.05M
3
QURE icon
uniQure
QURE
+$5.02M
4
HUM icon
Humana
HUM
+$3.07M
5
ABBV icon
AbbVie
ABBV
+$2.95M

Sector Composition

1 Healthcare 98.09%
2 Industrials 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
26
Cigna
CI
$78.8B
$2.31M 1.06%
11,293
+293
+3% +$53.7K
MTEM
27
DELISTED
Molecular Templates, Inc.
MTEM
$2.25M 1.03%
10,726
-4,140
-28% -$595K
CUE icon
28
Cue Biopharma
CUE
$120M
$2.19M 1%
+4,588
New +$1.44M
PRTK
29
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.81M 0.83%
+450,000
New +$1.56M
TNET icon
30
TriNet
TNET
$2.64B
$1.59M 0.73%
+28,104
New +$1.56M
KZR
31
DELISTED
Kezar Life Sciences
KZR
$1.28M 0.59%
+32,000
New +$985K
TLGT
32
DELISTED
Teligent, Inc
TLGT
$632K 0.29%
148,453
-96,151
-39% -$597K
MIST icon
33
Milestone Pharmaceuticals
MIST
$158M
$616K 0.28%
+38,481
New +$681K
BMY icon
34
Bristol-Myers Squibb
BMY
$120B
$520K 0.24%
8,100
-296,800
-97% -$17M
APEN
35
DELISTED
Apollo Endosurgery, Inc.
APEN
$454K 0.21%
+159,336
New +$461K
ABBV icon
36
AbbVie
ABBV
$431B
– –
-39,000
Closed -$2.95M
ADMA icon
37
ADMA Biologics
ADMA
$2.01B
– –
-548,409
Closed -$2.44M
ALLK
38
DELISTED
Allakos
ALLK
– –
0
– –
AXSM icon
39
Axsome Therapeutics
AXSM
$12.2B
– –
0
– –
GH icon
40
Guardant Health
GH
$21.6B
– –
-41,700
Closed -$2.66M
HUM icon
41
Humana
HUM
$49B
– –
-12,000
Closed -$3.07M
TPST icon
42
Tempest Therapeutics
TPST
$17.1M
– –
-267
Closed -$370K
QTTB icon
43
Q32 Bio
QTTB
$266M
– –
-8,517
Closed -$2.77M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-587,626
Closed -$2.31M
HNGR
45
DELISTED
Hanger Inc.
HNGR
– –
-395,000
Closed -$8.05M
SRRA
46
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-59,168
Closed -$924K
UROV
47
DELISTED
Urovant Sciences Ltd.
UROV
– –
-102,657
Closed -$972K
1
2

Similar funds

PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return
BFC
Blue Fin Capital Warren, Rhode Island $610M AUM 26.46% 1-Year Est. Return
ACM
Armbruster Capital Management Pittsford, New York $610M AUM 17.51% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $610M AUM 25.92% 1-Year Est. Return
SAM
Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return
CBB
Citizens Business Bank Ontario, California $610M AUM 27.86% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
IA
IFG Advisors St. Louis, Missouri $611M AUM 17.57% 1-Year Est. Return